Enzyme immunoassay for the quantitative determination of free Infliximab (Remicade®) in serum and plasma.
The Matriks Biotek Shikari® Infliximab-Remicade ELISA has been especially developed for the quantitative analysis of free infliximab in serum and plasma samples.
